Compound ID | 611

Update compound information

CHIR-090

Class: Lipopolysaccharide synthesis inhibitor (LpxC inhibitor)

Spectrum of activity: Gram-positive
Details of activity: LpxC Inhibitor, lipopolysaccharide synthesis inhibitor. A synthetic antibiotic (alkynyl hydroxamate) which has been shown to inhibit Pseudomonas aeruginosa, Neisseria meningitidis, and Helicobacter pylori
Institute where first reported: Novartis Inst. for BioMed. Res., Inc, USA
Year first mentioned: 2010
Highest developmental phase: Preclinical
Development status: Inactive
Reason Dropped: CHIR 090's was discontinued due to problems with developing resistance (2)
Chemical structure(s):
Click here for structure editor
Molecular weight: 437.49
Iso. SMILES: C[C@H]([C@@H](C(=O)NO)NC(=O)C1=CC=C(C=C1)C#CC2=CC=C(C=C2)CN3CCOCC3)O
InChI Key: FQYBTYFKOHPWQT-VGSWGCGISA-N
Can. SMILES: C[C@H]([C@@H](C(=O)NO)NC(=O)C1=CC=C(C#CC2=CC=C(C=C2)CN3CCOCC3)C=C1)O
InChI: InChI=1S/C24H27N3O5/c1-17(28)22(24(30)26-31)25-23(29)21-10-8-19(9-11-21)3-2-18-4-6-20(7-5-18)16-27-12-14-32-15-13-27/h4-11,17,22,28,31H,12-16H2,1H3,(H,25,29)(H,26,30)/t17-,22+/m1/s1
External links:
PubChem link: https://pubchem.ncbi.nlm.nih.gov/compound/11546620
Citations:
  • https://www.nature.com/articles/ja201349.pdf
  • http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2709454/

  • AntibioticDB is supported by GARDP.

    If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

    The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.